「world health organization」の検索結果
6件：1～5件目を表示
-
Management Policy | About Senju | SENJU Pharmaceutical
ion（of our ideal future） To provide care that is effective for the five senses of people around the world A company that persistently creates and provides original and high-quality pharmaceutical prod...
https://www.senju.co.jp/english/about/philosophy.html -
Research and Development System | Research & Development | SENJU Pharmaceutica
erefore, we engage in R&D in an open environment. Finally, patients suffer from ocular diseases worldwide. There are no borders for diseases and no borders in our research and development activiti...
http://www.senju.co.jp/english/rd/about/ -
Management Policy | About Senju | SENJU Pharmaceutical
ion（of our ideal future） To provide care that is effective for the five senses of people around the world A company that persistently creates and provides original and high-quality pharmaceutical prod...
http://www.senju.co.jp/english/about/philosophy.html -
Product Development Policy | Research & Development | SENJU Pharmaceutica
ntribute to maintenance and improvement of “a joy to behold” or QOV (Quality of Vision) of patients worldwide. We commercialized senile cataract drugs in 1958, and subsequently, antimicrobial ophthalm...
http://www.senju.co.jp/english/rd/policy/ -
产品开发方针 | 研究与开发 | 千寿制药株式会社
性结膜炎治疗药（在日本属于罕见病治疗用药品）、青光眼和高眼压治疗药等产品。另外，我们通过各种化学仿制药和生物类似药，帮助患者减轻了经济负担。 另一方面，眼部疾病多种多样，WHO在2019年发布的报告（World report on vision）中提到全世界有22亿人以上视力受损或失明，而其中10亿人以上未得到必要的治疗。并且报告中还提到白内障、屈光不正（近视、老花眼等）、老年性黄斑变性、青光眼、...
http://www.senju.co.jp/chinese/rd/policy/